| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/31.SUPPL_A.87 |
| P698 | PubMed publication ID | 8383658 |
| P2093 | author name string | C Chidiac | |
| O Leroy | |||
| E Senneville | |||
| C Beuscart | |||
| Y Mouton | |||
| F Ajana | |||
| P Lecocq | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | piperacillin/tazobactam | Q7197337 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 87-95 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections | |
| P478 | volume | 31 Suppl A |
| Q35650111 | Cross-Canada survey of resistance of 2747 aerobic blood culture isolates to piperacillin/tazobactam and other antibiotics |
| Q53946960 | Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia. |
| Q54616485 | National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers |
| Q35825356 | Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis |
| Q33761118 | Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection |
| Q40471195 | Piperacillin/Tazobactam: A New Beta-Lactam/Beta-Lactamase Inhibitor Combination |
| Q72811538 | Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review |
| Q74683283 | Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital |
| Q40389389 | Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential |
| Q34458678 | Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections |
| Q33649676 | Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections |
| Q44019734 | Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections |
| Q33701687 | Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis |
| Q54200563 | Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy. |
| Q39867395 | Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children |
| Q35891315 | Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates |
| Q33928681 | Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations |
Search more.